loading…

N02.0 Recurrent and persistent hematuria with minor glomerular abnormality

BackN02Recurrent and persistent hematuria12 →N02.0Recurrent and persistent hematuria with minor glomerular abnormalityN02.1Recurrent and persistent hematuria with focal and segmental glomerular lesionsN02.2Recurrent and persistent hematuria with diffuse membranous glomerulonephritisN02.3Recurrent and persistent hematuria with diffuse mesangial proliferative glomerulonephritisN02.4Recurrent and persistent hematuria with diffuse endocapillary proliferative glomerulonephritisN02.5Recurrent and persistent hematuria with diffuse mesangiocapillary glomerulonephritisN02.6Recurrent and persistent hematuria with dense deposit diseaseN02.7Recurrent and persistent hematuria with diffuse crescentic glomerulonephritisN02.8Recurrent and persistent hematuria with other morphologic changesN02.9Recurrent and persistent hematuria with unspecified morphologic changesN02.ARecurrent and persistent hematuria with C3 glomerulonephritisN02.BRecurrent and persistent immunoglobulin A nephropathy7 →N02.B1Recurrent and persistent immunoglobulin A nephropathy with glomerular lesionN02.B2Recurrent and persistent immunoglobulin A nephropathy with focal and segmental glomerular lesionN02.B3Recurrent and persistent immunoglobulin A nephropathy with diffuse membranoproliferative glomerulonephritisN02.B4Recurrent and persistent immunoglobulin A nephropathy with diffuse membranous glomerulonephritisN02.B5Recurrent and persistent immunoglobulin A nephropathy with diffuse mesangial proliferative glomerulonephritisN02.B6Recurrent and persistent immunoglobulin A nephropathy with diffuse mesangiocapillary glomerulonephritisN02.B9Other recurrent and persistent immunoglobulin A nephropathy
CategoryCODABLE
N02.0
Recurrent and persistent hematuria with minor glomerular abnormality
EXAMPLES
Recurrent and persistent hematuria with minimal change lesion
Chapter
XIV · Diseases of the genitourinary system
Section
N00-N08
Valid from
Source

CMS ICD-10-CM Tabular List, edition FY2026.